Tamoxifen

規格

10540-29-1CAS番号

234-118-0EC番号

2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamineIUPAC名

C26H29NO化学式

371.5 g/mol分子量

tamoxifen; 10540-29-1; trans-Tamoxifen; Crisafeno; Tamoxifene; Diemon; Tamoxifeno; Citofen; Istubol; Oncomox; Retaxim; Tamizam; Tamoxen; Valodex; Tamoxifenum; Mammaton; Novaldex; Tamoplex; Apo-Tamox; ICI 47699; ICI-47699; (Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; DTXSID1034187; 1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; 1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene; 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine; NSC-727681; (z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxy]-n,n-dimethylethanamine; (2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)dimethylamine; 094ZI81Y45; DTXCID9014187; CHEBI:41774; Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (Z)-; Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethyl-; (Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine; Ethanamine, 2-(4-((1Z)-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-; 2-(4-((Z)-1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine; (2-(4-((1Z)-1,2-diphenylbut-1-en-1-yl)phenoxy)ethyl)dimethylamine; 2-(4-((Z)-1,2-di(phenyl)but-1-enyl)phenoxy)-N,N-dimethylethanamine; 2-[4-[(Z)-1,2-di(phenyl)but-1-enyl]phenoxy]-N,N-dimethylethanamine; ICI-46,474; RefChem:6281; L02BA01; ICI46474; ICI47699; ICI46,474; 1-p-beta-dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene; 234-118-0; Caditam; Tamoxifene [INN-French]; Tamoxifenum [INN-Latin]; Tamoxifeno [INN-Spanish]; Tamoxifen (INN); Tamoxifen (Standard); CHEMBL83; 2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine; (Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE; Tamoxifen (Z); (Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene; TAMOXIFEN [INN]; (Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine; 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethyl-ethanamine; Tamoxifen [INN:BAN]; Tamoxifen (1.0 mg/mL in Methanol); [3H]tamoxifen; [3H]-tamoxifen; Tamoplex (TN); SMR000059172; CAS-10540-29-1; TRANS FORM OF TAMOXIFEN; CCRIS 3275; HSDB 6782; EINECS 234-118-0; ,citrate; Tamoxifen?; Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-; UNII-094ZI81Y45; Ethylamine, N,N-dimethyl-2-(p-(1,2-diphenyl-1-butenyl)phenoxy)-, (Z)-; ETHANAMINE, 2-(4-((1Z)-1,2-DIPHENYL-1-BUTEN-1-YL)PHENOXY)-N,N-DIMETHYL-; Tamoxifen, 7; (Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC); Tocris-0999; 1ya4; Tamoxifen, >=99%; TAMOXIFEN [MI]; TAMOXIFEN [HSDB]; TAMOXIFEN [IARC]; Prestwick2_000146; Prestwick3_000146; Spectrum5_001417; Spectrum5_002043; TAMOXIFEN [VANDF]; UPCMLD-DP027; EC 234-118-0; SCHEMBL4084; TAMOXIFEN [WHO-DD]; BIDD:PXR0003; Lopac0_001203; BSPBio_000252; BSPBio_001150; BSPBio_001982; MLS001332535; MLS001332536; BIDD:ER0008; BIDD:GT0009; Tamoxifen, analytical standard; Tamoxifen - Bio-X trade mark; BPBio1_000278; GTPL1016; GTPL5384; orb1222899; orb2281178; orb3025057; 2-{4-[(1Z)-1,2-Diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethan-1-amine; BDBM20607; cid_2733526; cMAP_000044; GLXC-06537; HMS1362J11; HMS1792J11; HMS1990J11; HMS2090N08; HMS2232C12; HMS3261D09; HMS3403J11; HMS3411P04; HY-13757AR; Tamoxifen (1 mg/mL in Methanol); MSK10364; Tox21_201243; Tox21_300539; Tox21_500494; (Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine; 1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene; EBC-12635; HB0601; HY-13757A; MFCD00010454; NSC727681; AKOS022143035; CCG-205277; DB00675; FD12063; FT27994; KS-1472; LP00494; SDCCGSBI-0051170.P007; ICI47699;Z-Tamoxifen;trans-Tamoxifen; IDI1_000258; IDI1_002170; QTL1_000079; NCGC00024928-01; NCGC00024928-03; NCGC00024928-04; NCGC00024928-05; NCGC00024928-07; NCGC00024928-08; NCGC00024928-09; NCGC00024928-10; NCGC00024928-11; NCGC00024928-12; NCGC00024928-13; NCGC00024928-14; NCGC00024928-15; NCGC00024928-16; NCGC00024928-17; NCGC00024928-18; NCGC00024928-19; NCGC00024928-33; NCGC00024928-39; NCGC00024928-40; NCGC00254455-01; NCGC00258795-01; NCGC00261179-01; AC-35768; BT164438; SBI-0051170.P004; CS-0694848; NS00010353; T6906; C07108; D08559; AB00053547-16; AB00053547-17; AB00053547-18; AB00053547_19; AB00053547_20; EN300-1273241; L024126; Q412178; BRD-K93754473-001-02-9; BRD-K93754473-048-04-6; BRD-K93754473-048-05-3; BRD-K93754473-048-10-3; BRD-K93754473-048-18-6; BRD-K93754473-048-19-4; BRD-K93754473-048-20-2; BRD-K93754473-048-21-0; Tamoxifen, certified reference material, TraceCERT(R); Z2527624834; (Z)-2-(4-(1,2-diphenylbut-1-en-1-yl)phenoxy)-N,N-dimethylethanamine; (Z)-2-(4-(1,2-diphenylbut-1-en-1-yl)phenoxy)-N,N-dimethylethanamine; trans-?2-?[4-?(1,2-?Diphenyl-?1-?butenyl)?phenoxy]?-N,N-dimethylethylamine; Tamoxiphen別名